Annexon, Inc. (ANNX) reporting calendar
Annexon, Inc. files periodic reports with the SEC as ANNX on Nasdaq. Atlas tracks 24 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 18 Jul 2026 – 8 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 24
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ANNX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-211931 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001193125-26-131782 |
| 10-Q | 30 Sep 2025 | 10 Nov 2025 | 41 days | 0001193125-25-274240 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0000950170-25-108869 |
| 10-Q | 31 Mar 2025 | 12 May 2025 | 42 days | 0000950170-25-069200 |
| 10-K | 31 Dec 2024 | 3 Mar 2025 | 62 days | 0000950170-25-030849 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0000950170-24-127057 |
| 10-Q | 30 Jun 2024 | 12 Aug 2024 | 43 days | 0000950170-24-095401 |
| 10-Q | 31 Mar 2024 | 13 May 2024 | 43 days | 0000950170-24-058659 |
| 10-K | 31 Dec 2023 | 26 Mar 2024 | 86 days | 0000950170-24-036408 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0000950170-23-062913 |
| 10-Q | 30 Jun 2023 | 7 Aug 2023 | 38 days | 0000950170-23-039054 |
| 10-Q | 31 Mar 2023 | 8 May 2023 | 38 days | 0000950170-23-018797 |
| 10-K | 31 Dec 2022 | 6 Mar 2023 | 65 days | 0000950170-23-006232 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0000950170-22-021509 |
| 10-Q | 30 Jun 2022 | 8 Aug 2022 | 39 days | 0000950170-22-015560 |
| 10-Q | 31 Mar 2022 | 9 May 2022 | 39 days | 0000950170-22-008494 |
| 10-K | 31 Dec 2021 | 1 Mar 2022 | 60 days | 0001564590-22-008044 |
| 10-Q | 30 Sep 2021 | 9 Nov 2021 | 40 days | 0001564590-21-055728 |
| 10-Q | 30 Jun 2021 | 16 Aug 2021 | 47 days | 0001564590-21-044624 |
| 10-Q | 31 Mar 2021 | 17 May 2021 | 47 days | 0001564590-21-028390 |
| 10-K | 31 Dec 2020 | 25 Mar 2021 | 84 days | 0001564590-21-015262 |
| 10-Q | 30 Sep 2020 | 16 Nov 2020 | 47 days | 0001564590-20-054172 |
| 10-Q | 30 Jun 2020 | 8 Sep 2020 | 70 days | 0001193125-20-241119 |
Source: SEC EDGAR company submissions for CIK 0001528115. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.